SALT LAKE CITY, Dec. 27, 2013 (GLOBE NEWSWIRE) -- The American Board of Pathology (ABP) and ARUP Laboratories are pleased to announce that ARUP's president and CEO, Dr. Edward Ashwood, has been selected as a trustee to the ABP board beginning January 2014.
Dr. Ashwood joined ARUP in 1985 and, in addition to his duties as ARUP's CEO and president, is a professor of pathology at the University of Utah School of Medicine. He received his MD from the University of Colorado and completed a laboratory medicine residency in clinical pathology at the University of Washington. He is board certified in clinical and chemical pathology, and his research interests include the clinical chemistry of pregnancy and standardization of assays.
As a board trustee, Dr. Ashwood is responsible for developing and reviewing certification examination questions and administering certification examinations in Pathology and the subspecialties of Pathology. Other trustee duties include interacting with the American Board of Medical Specialties (ABMS), Pathology Residency programs, and other Pathology professional organizations. As a new board member, Dr. Ashwood will be chairing the Test Development Advisory Committee in Chemical Pathology.
"The American Board of Pathology plays a critical role in the of practice pathology and laboratory medicine," said Dr. Ashwood. "I am honored to serve alongside such a distinguished board."
As a member of the American Board of Medical Specialties, the ABP promotes public health and advances the practice and science of pathology by establishing voluntary certification standards and assessing the qualifications of those seeking to practice the specialty of pathology.
For more information about Dr. Ashwood or the ABP Board, visit the American Board of Pathology Officers and Trustees page.
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®.
Photos accompanying this release are available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=22830
